KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Assets Average (2018 - 2025)

Historic Assets Average for Bionano Genomics (BNGO) over the last 8 years, with Q3 2025 value amounting to $77.5 million.

  • Bionano Genomics' Assets Average fell 2844.79% to $77.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.5 million, marking a year-over-year decrease of 2844.79%. This contributed to the annual value of $145.5 million for FY2024, which is 4422.87% down from last year.
  • Bionano Genomics' Assets Average amounted to $77.5 million in Q3 2025, which was down 2844.79% from $77.2 million recorded in Q2 2025.
  • Bionano Genomics' 5-year Assets Average high stood at $370.8 million for Q2 2021, and its period low was $77.2 million during Q2 2025.
  • For the 5-year period, Bionano Genomics' Assets Average averaged around $232.4 million, with its median value being $226.6 million (2023).
  • Per our database at Business Quant, Bionano Genomics' Assets Average surged by 150167.15% in 2021 and then tumbled by 5861.0% in 2024.
  • Over the past 5 years, Bionano Genomics' Assets Average (Quarter) stood at $368.4 million in 2021, then fell by 14.33% to $315.6 million in 2022, then crashed by 37.21% to $198.2 million in 2023, then crashed by 58.61% to $82.0 million in 2024, then dropped by 5.46% to $77.5 million in 2025.
  • Its Assets Average stands at $77.5 million for Q3 2025, versus $77.2 million for Q2 2025 and $77.5 million for Q1 2025.